Friday, 27 October 2017

KIDNEY Problems (Dialysis)

 

SICKNESS:

  • Kidney Problems (Dialysis)

BENEFITS THRU’ DXN PRODUCTS:

  • Improves Kidney functions
  • Controls Urea and Creatinin
  • Balances the Bio-chemistry
  • Helps reduction of frequency of Dialysis
  • Balances body fluids; Reduces Oedema
  • Helps prevention of further Kidney damage
  • Reduces body pains; Protects Heart & Lungs

PRODUCTS RECOMMENDATIONS:

  • RG, GL, Spirulina, DXN Gano Tea, Morinzhi.






 http://iocbusiness.blogspot.com.es/p/products_6.html 
http://iocbusiness.blogspot.com.es/p/blog-page_34.html 
https://www.facebook.com/messages/t/marktacordadotcom 

DXN Products are basically Supplements with miraculous healing property of THE BODY through TRIPLE ACTION:

  • Removal of Toxins & Toxicity in the Body.
  • Balancing the Bio-Chemicals and Bio-Electricity in the System.
  • Providing Vital (Therapeutic) Minerals & Trace Elements to strengthen the Body.

Therefore, DXN Products may be consumed by ALL Humans-beings: Healthy, Sick as well as Terminal patients. The TRIPLE-OBJECTIVES of DXN consumption are:

  • PREVENT diseases in the case of Healthy (and vulnerable to sickness) people.
  • PROTECT and help Recovery for the Chronic / Terminal Patients.
  • PRESERVE healthy Functions of the body, Reduce sufferings and Extend life-span
Thus DXN products offer TOTAL and COMPLETE Health Solution to all.

The DXN Products differ from Drugs (Medicines) and Chemicals, in nature and actions.

  • DXN products are Supplements only.
  • They may be consumed along with any other line of Medical treatment.
  • They are used as Coactive / Adjuvant Therapy. No Side Effects.
  • NO INTERACTION with other lines of treatments & drugs.
  • No Dosage specificity.
  • Large volumes of consumption & prolonged usage: SAFE & NON TOXIC.
Based on the scientific studies and practical experience with patients, by Medical Professionals and Experts, the following suggestions are furnished.


Did This Help You?
If so, I would greatly appreciate it if you commented below and shared on Facebook …


No comments:

Post a Comment